Skip to main content

Site notifications

PHELINUN Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Product name
PHELINUN
Accepted date
Sep-2023
Active ingredients
melphalan hydrochloride
Proposed indication
As a conditioning regimen prior to haematopoietic stem cell transplantation in malignant haematological diseases.
Application type
C (new indication)
Publication date
Sep-2023
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.

Help us improve the Therapeutic Goods Administration site